|
Session 36
Oral Abstracts
HIV Testing and ART in Resource-constrained Settings
Wednesday, 10 am-12 noon
Room: Room 517a |
| 10:00 am 137LB |
HIV Prevalence and Unmet Need for HIV Testing, Care and Treatment in Kenya: Results of a Nationally Representative Survey
Ibrahim Mohammed*1, S Dadabhai2, C Omolo3, T Galgalo4, T Oluoch5, G Kichamu6, R Bunnell5, P Muriithi7, J Mermin5, and R Kaiser5
1Natl AIDS/STI Control Prgm, Nairobi, Kenya; 2Univ of California, San Francisco, Nairobi, Kenya; 3Kenya Natl Bureau of Statistics, Nairobi; 4Natl Publ Hlth Lab Svcs, Nairobi, Kenya; 5CDC Kenya, Nairobi; 6Natl Coordinating Agency for Population and Devt, Nairobi, Kenya; and 7Natl AIDS Control Council, Nairobi, Kenya |
| 10:15 am 138 |
Comparison of Home- and Clinic-based HIV Counseling and Testing among Household Members of Persons Taking ART: Uganda
E Lugada1, S Jaffar2, J Levin2, B Abang1, J Mermin1, G Namara2, H Grosskurth2, E Mugalanzi3, Sundeep Gupta*1, and R Bunnell1
1CDC Uganda, Entebbe; 2Med Res Council, Uganda Virus Res Inst, Entebbe; and 3AIDS Support Org, Kampala, Uganda |
| 10:30 am 139 |
Population-level Changes in Knowledge of HIV Status, Stigma, and HIV Risk Behavior after District-wide Door-to-Door Voluntary Counseling and Testing: Bushenyi District, Uganda
F Nuwaha1, E Tumwesigye2, S Kasasa1, S Asiimwe2, G Wana2, M Achom3, D Kabatesi3, S Malamba3, J Tappero3, and Sundeep Gupta*3
1Makerere Univ Sch of Publ Hlth, Kampala, Uganda; 2Integrated Community-Based Initiatives, Bushenyi, Uganda; and 3CDC Uganda, Entebbe |
| 10:45 am 140 |
Changing Mortality Risk Associated with CD4 Cell Response to Long-term ART: Sub-Saharan Africa
Stephen Lawn*1,2, F Little1, L-G Bekker1, R Kaplan1, E Campbel1, C Orrell1, and R Wood1
1Univ of Cape Town, South Africa and 2London Sch of Hygiene and Tropical Med, UK |
| 11:00 am 141 |
Mortality of HIV-infected Patients Starting ART: Comparisons with the General Population in Southern Africa
Martin Brinkhof*1, A Boulle2, R Weigel3, E Messou4, C Mathers5, C Orrell2, M Pascoe6, F Dabis6, M Egger1, and the Intl Epidemiological Databases to Evaluate AIDS (IeDEA)
1Univ of Bern, Switzerland; 2Univ of Cape Town, South Africa; 3Lighthouse Clin, Lilongwe, Malawi; 4CEPREF, Abidjan, Côte d`Ivoire; 5WHO, Geneva, Switzerland; and 6Connaught Clin, Harare, Zimbabwe |
| 11:15 am 142 |
First-line Tenofovir ART: Zambia
Albert Mwango*1, M Giganti2,3, L Mulenga2, S Reid2,3, A Chisembele-Taylor2, N Chintu2, B Chi2,3, E Stringer2,3, and J Stringer2,3
1Zambian Ministry of Hlth, Lusaka; 2Ctr for Infectious Disease Res in Zambia, Lusaka; and 3Univ of Alabama at Birmingham, US |
| 11:30 am 143 |
Randomized Trial of Trained Patient-nominated Treatment Supporters Providing Partial Directly Observed ART in South African Adults Initiating HIV Therapy
Jean Nachega*1,2, R Goliath2, A Efron1, M Chaudhary1, M Ram1, C Morroni2, H Schoeman2, R Chaisson1, and G Maartens2
1Johns Hopkins Univ, Baltimore, MD, US and 2Univ of Cape Town, South Africa |
| 11:45 am 144 |
Evaluation of the WHO Immunologic Criteria for ART Failure among Adults in Rakai, Uganda
Steven Reynolds*1,2, G Nakigozi3, K Newell4, A Ndyanabo3, R Galiwongo3, I Boaz3, T Quinn1,2, R Gray5, M Wawer5, and D Serwadda6
1Johns Hopkins Univ Sch of Med, Baltimore, MD, US; 2NIAID, NIH, Bethesda, MD, US; 3Rakai Hlth Sci Prgm, Entebbe, Uganda; 4SAIC, Frederick, MD, US and NCI, Frederick, MD, US; 5Johns Hopkins Univ Bloomberg Sch of Publ Hlth, Baltimore, MD, US; and 6Makerere Univ Sch of Publ Hlth, Kampala, Uganda |
|
